Company Analysis

Wave Life Sciences Ltd. (WVE)

Nasdaq: WVE · Pharmaceutical Preparations · Singapore, SG · filing with the SEC since 2015
Grade6.1
◀ Past 5.9● Present 6.6▶ Future 5.6
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 26, 2026Mar 4, 2025Mar 6, 2024Mar 23, 2023Mar 3, 2022Mar 4, 2021Mar 2, 2020Mar 1, 2019Mar 12, 2018Mar 16, 2017
Revenue42,727108,302113,3053,64940,96420,07715,98314,4143,8931,092
Research and development182,779159,682130,009115,856121,875130,944175,431134,42879,30940,818
General and administrative75,33159,02351,29250,51346,10542,51048,86939,50926,97515,994
Total operating expenses258,110218,705181,301166,369167,980173,454224,300173,937106,28456,812
Operating income-215,383-110,403-67,996-162,720-127,016-153,377-208,317-159,523-102,391r-55,720r
Interest and investment income10,47810,1637,9281,57130568····
Interest income (expense), net·····-1629226337
Other income (expense), net5273,2321,87874,5372,0589,7389,549-331-50
Total non-operating income (expense)11,00513,3959,8061,5784,5672,62614,67912,9391,253542
Income before income taxes-204,378-97,008-58,190-161,142-122,449-150,751-193,638-146,584-101,138r-55,178r
Income tax expense00-677681-204-841069842r482r
Net income including non-controlling interests-204,378-97,008-57,513-161,823-122,245-149,910-193,638-146,653-101,980-55,660
Net income-204,378-97,008-57,513-161,823-122,245-149,910-193,638-146,653-101,980r-55,660r
Net income to common shareholders-204,378-97,008-57,513-161,823-122,245-149,910-193,638-146,653-101,980r-55,660r
Earnings per share, basic-1.21-0.70-0.54-2.05-2.36·····
Earnings per share, diluted-1.21-0.70-0.54-2.05-2.36·····
Earnings per share, basic and diluted····-2.36-3.82-5.72-5.06-3.85-2.44r
Weighted average shares, basic168,649,795138,277,468106,097,26878,855,81051,825,566·····
Weighted average shares, diluted168,649,795138,277,468106,097,26878,855,81051,825,566·····
Weighted average shares, basic and diluted····51,825,56639,227,61833,866,48728,970,40426,513,38222,800,628
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterestAndDividend
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton WVE · research, not advice